Date & Time of CTFG
Time: 12:15pm - 19:00pm (CTFG is open to public)
Location
Matrix Building, Level 4
Creation Theatrette 30 Biopolis Street Singapore 138671 |
|
Programme
Time |
|
11.30 – 12.15 |
SCSS AGM 2018 (Restricted
to SCSS members only!) |
12.15 – 13.00 |
Lunch Networking |
13.00– 13.15 |
Welcome & Introduction to CTFG Launch Ray DUNN & John DANGERFIELD (Open to public) |
13.15-14.55 |
Session
1 (Chair: Shigeki SUGII, Singapore Bioimaging
Consortium) |
13.15- 13.40 |
Glycosaminoglycans as Adjuvants for Enhanced Cellular
Therapy Simon COOL, Institute of Medical Biology,
Singapore |
13.40 – 14.05 |
Growing and Using Blood Stem Cells: Already a
Reality William HWANG, Singapore General Hospital |
14.05 – 14.30 |
A Co-operative Framework for Encouraging
Responsible Innovation with Autologous Cellular Therapies Tamra LYSAGHT, National University of Singapore |
14:30 – 14:55 |
The Next Generation of T Cell Therapy to Tackle
the Solid Tumor Challenge John CONNOLLY, TESSA Therapeutics, Singapore |
14.55 – 15.30 |
Tea break |
15.30 – 16:45 |
Session 2 (Chair: John DANGERFIELD, AustriaNova,
Singapore) |
15.30 – 15.55 |
TCR-T Cell Product Development Strategy from
Lab to Market Lietao Victor LI, Lion TCR,
Singapore |
15.55 – 16.20 |
An Overview of Cell-based Therapy in Malaysia Angela NG, Universiti
Kebangsaan Malaysia Medical Centre, Malaysia |
16.20 – 16.45 |
Clinical Outcomes of Mesenchymal Stem Cell
(MSC) Therapy for Cartilage Regeneration in Singapore James HUI, National University Health System,
Singapore |
16:45 – 16:50 |
Announcement: Duke-NUS, BioLamina
and Novo Nordisk enter collaborative research on stem cell-based therapy for
heart and eye diseases Karl Tryggvason, Duke-NUS, Singapore |
16:50 – 17:30 |
Panel Discussion Fostering Translational Research (Moderators: Tamra LYSAGHT & Ray DUNN) Panel members: James Hui, Simon Cool, John
Connolly |
17.30 – 19:00 |
Wine & Dinner networking |